You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EGFR wild-type (wt)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC (NSCLC) Trial in China (Capmatinib)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Xiamen, Fujian, China
  • +18 more
Jan 27, 2023

Lung Cancer Trial (Savolitinib, Durvalumab)

Recruiting
  • Lung Cancer
  • Beijing, China
  • +2 more
Jan 11, 2023

NSCLC Trial in Worldwide (INC280 (capmatinib))

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • INC280 (capmatinib)
  • Long Beach, California
  • +95 more
Dec 29, 2022

Metastatic Colorectal Cancer. Real-World Data Analysis.

Completed
  • Metastatic Colorectal Cancer
    • Istanbul, Turkey
      Istanbul Medeniyet University Hospital
    Oct 25, 2021

    Efficacy Trial in Suzhou (TAB008, Bevacizumab)

    Completed
    • Efficacy
    • Suzhou, Jiangsu, China
      TOT
    Jun 16, 2022

    Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))

    Completed
    • Colorectal Cancer Metastatic
    • C-met Overexpression
    • Tivantinib (ARQ197)
    • Rozzano, Milano, Italy
      Istituto Clinico Humanitas
    Sep 8, 2022

    Stage IV Melanoma, Stage III Melanoma Trial in Jette (Trametinib, Dabrafenib)

    Recruiting
    • Stage IV Melanoma
    • Stage III Melanoma
    • Jette, Brussels, Belgium
      Universitair Ziekenhuis Brussel
    Sep 29, 2021

    Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)

    Recruiting
    • Metastatic Colorectal Cancer
    • Sodium Valproate
    • +2 more
    • Saint Leonards, New South Wales, Australia
    • +8 more
    Jan 22, 2023

    NSCLC, Squamous Non-small-cell Lung Cancer, Squamous Non-Small Cell Tumor of Lung Trial in United States (sapanisertib)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +3 more
    • Davis, California
    • +13 more
    Nov 7, 2022

    Metastatic Colorectal Cancer Trial in Worldwide (Futuximab/modotuximab, Trifluridine/Tipiracil)

    Recruiting
    • Metastatic Colorectal Cancer
    • Ann Arbor, Michigan
    • +10 more
    Dec 2, 2022

    Circulating Tumour DNA Testing in Assessing for Alterations of

    Recruiting
    • Colorectal Cancer
      • Singapore, Singapore
        National University Hospital
      Sep 28, 2021

      Colorectal Cancer, Metastatic Colorectal Cancer, RAS Mutation Trial in Italy (Bevacizumab, Cetuximab, 5-FU)

      Recruiting
      • Colorectal Cancer
      • +2 more
      • Coppito, L'Aquila, Italy
      • +3 more
      Sep 10, 2021

      Nonsquamous NSCLC Trial in Yichang (Sintilimab, Docetaxel, Pemetrexed)

      Recruiting
      • Nonsquamous Non-Small Cell Lung Cancer
      • Yichang, Hubei, China
        Department of Medical Oncology, Central Hospital of Yichang City
      Nov 5, 2021

      Colo-rectal Cancer Trial in Beijing (Experimental: mXELOX plus cetuximab, Active Comparator: FOLFOX plus cetuximab)

      Recruiting
      • Colo-rectal Cancer
      • Experimental: mXELOX plus cetuximab
      • Active Comparator: FOLFOX plus cetuximab
      • Beijing, China
        Cancer Hospital & Institute, Chinese Academy of Medical Sciences
      Sep 29, 2021

      Metastatic Colorectal Cancer Trial in United States (Trastuzumab, Cetuximab, Neratinib)

      Active, not recruiting
      • Metastatic Colorectal Cancer
      • Anaheim, California
      • +47 more
      Mar 28, 2022

      Nonsquamous Nonsmall Cell Tumor of Lung Trial in Taipei (BLEX 404)

      Not yet recruiting
      • Nonsquamous Nonsmall Cell Neoplasm of Lung
      • BLEX 404
      • Taipei, Taiwan
        Taipei Veteran General Hospital
      Feb 28, 2023

      Lung Adenocarcinoma Trial in ZhengZhou (CIK, chemo)

      Terminated
      • Lung Adenocarcinoma
      • ZhengZhou, Henan, China
        Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
      May 10, 2021

      NSCLC Trial in Worldwide (Capmatinib, Spartalizumab, Docetaxel)

      Completed
      Has Results
      • Carcinoma, Non-Small-Cell Lung
      • Fayetteville, Arkansas
      • +7 more
      Jan 21, 2022

      Colorectal Cancer Trial in Pisa (Regorafenib, Panitumumab)

      Recruiting
      • Colorectal Cancer
      • Pisa, PI, Italy
        U.O. Oncologia 2 Universitaria
      Aug 3, 2022

      Advanced Colorectal Cancer Trial in Seoul (Cetuximab, irinotecan)

      Completed
      • Advanced Colorectal Cancer
      • Cetuximab, irinotecan
      • Seoul, Korea, Republic of
        Asan Medical Center
      Jan 17, 2021

      Nonsquamous NSCLC Trial in Yichang (Sintilimab, Docetaxel, Pemetrexed)

      Recruiting
      • Nonsquamous Non-Small Cell Lung Cancer
      • Yichang, Hubei, China
        Department of Medical Oncology, Central Hospital of Yichang City
      Nov 5, 2021

      NSCLC Trial in Guangzhou (SBRT, Tislelizumab)

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      May 17, 2022

      Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma, Microsatellite

      Recruiting
      • Advanced Microsatellite Stable Colorectal Carcinoma
      • +5 more
      • Atlanta, Georgia
      • +2 more
      Oct 29, 2021

      Advanced Colorectal Cancer Trial in Cyprus, Greece (Panitumumab)

      Terminated
      • Advanced Colorectal Cancer
      • Strovolos, Nicosia, Cyprus
      • +7 more
      Jun 2, 2021

      Advanced Solid and Hematological TP53wt Tumors Trial in Worldwide (HDM201, ancillary treatment)

      Completed
      • Advanced Solid and Hematological TP53wt Tumors
      • Boston, Massachusetts
      • +14 more
      May 20, 2021